Back to AMRX
Neuberger Berman Group LLC → AMRX
Neuberger Berman Group LLC AMRX Position History
Amneal Pharmaceuticals, Inc. • Healthcare
Quarters held
22
Latest value
$2.3M
Q2 2026
Peak value
$64.9M
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $30.2M |
| Q1 2025 | $1.2M |
| Q2 2025 | $29M |
| Q2 2025 | $1.1M |
| Q3 2025 | $35.8M |
| Q3 2025 | $1.4M |
| Q3 2025 | $35.8M |
| Q3 2025 | $1.4M |
| Q3 2025 | $35.8M |
| Q3 2025 | $1.4M |
| Q4 2025 | $44.4M |
| Q4 2025 | $1.7M |
| Q4 2025 | $44.4M |
| Q4 2025 | $1.7M |
| Q1 2026 | $44M |
| Q1 2026 | $1.7M |
| Q1 2026 | $44M |
| Q1 2026 | $1.7M |
| Q2 2026 | $64.9M |
| Q2 2026 | $2.3M |
| Q2 2026 | $64.9M |
| Q2 2026 | $2.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $2.3M | 135.7K | — | — |
| Q2 2026 | $64.9M | 3.75M | — | — |
| Q2 2026 | $2.3M | 135.7K | — | — |
| Q2 2026 | $64.9M | 3.75M | — | — |
| Q1 2026 | $1.7M | 133.8K | — | — |
| Q1 2026 | $44M | 3.55M | — | — |
| Q1 2026 | $1.7M | 133.8K | — | — |
| Q1 2026 | $44M | 3.55M | — | — |
| Q4 2025 | $1.7M | 136.1K | — | — |
| Q4 2025 | $44.4M | 3.52M | — | — |
| Q4 2025 | $1.7M | 136.1K | — | — |
| Q4 2025 | $44.4M | 3.52M | — | — |
| Q3 2025 | $1.4M | 136.3K | — | — |
| Q3 2025 | $35.8M | 3.58M | — | — |
| Q3 2025 | $1.4M | 136.3K | — | — |
| Q3 2025 | $35.8M | 3.58M | — | — |
| Q3 2025 | $1.4M | 136.3K | — | — |
| Q3 2025 | $35.8M | 3.58M | — | — |
| Q2 2025 | $1.1M | 134.0K | — | — |
| Q2 2025 | $29M | 3.59M | — | — |
| Q1 2025 | $1.2M | 143.9K | — | — |
| Q1 2025 | $30.2M | 3.59M | — | — |
Other funds holding AMRX
$127.3M
$127.3M
$84.5M
$56.6M
$49.7M
$47.5M